Enacts the medical psilocybin act

This bill, known as the Medical Psilocybin Act, would create a regulated program allowing the use of psilocybin, a compound found in certain mushrooms, to treat specific medical conditions. It directly affects qualified patients diagnosed with issues such as treatment-resistant depression, post-traumatic stress disorder, substance use disorders, end-of-life care, or cluster headaches, as well as healthcare providers and businesses that produce or administer the substance. The legislation establishes a framework where licensed producers grow and prepare the medication, while licensed healthcare providers or trained supervisors determine appropriate dosing and oversee its administration in safe settings. Key provisions include creating a registry for patients and caregivers, setting strict safety and testing requirements for products, and providing exemptions from criminal penalties for the legal medical use and possession of psilocybin. The bill also mandates that the Department of Health develop detailed rules for licensing, training, recordkeeping, and monitoring to ensure the program operates safely and effectively.